|
Index of reports
> Cases resulting in life threatening events (46)
> Cases with Anaemia (6)
Below is the selection of adverse event reports related to Zyvox (Linezolid) that includes cases resulting in life threatening events where reactions include anaemia.
Adverse event in 67 year old male receiving Zyvox (Linezolid)
Reported by a physician from Italy on 2007-07-24
Patient: 67 year old male
Adverse reactions / side effects: Anaemia, Liver Function Test Abnormal, Thrombocytopenia, Haemolysis
Adverse event resulted in: life threatening event
Suspect drug(s):
Zyvox (Linezolid)
Other drugs received by patient: Clexane; Zithromax; Merrem; Diflucan
Adverse event in female receiving Zyvox (Linezolid)
Reported by a physician from United States on 2007-07-20
Patient: female, weighing 65.8 kg (144.8 pounds)
Adverse reactions / side effects: Hypersplenism, Haematocrit Decreased, Anaemia, Thrombocytopenia, Haemorrhagic Ascites, Blood Creatinine Increased
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Zyvox
Indication: Staphylococcal Infection
Intron A
Indication: Hepatitis C
Start date: 2007-01-01
End date: 2007-02-27
PEG-Intron
Dosage: daily dose:120mcg
Indication: Hepatitis C
Start date: 2007-02-01
End date: 2007-02-27
Ribavirin
Dosage: daily dose:200mg
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-01-01
End date: 2007-02-27
Ribavirin
Dosage: daily dose:200mg-freq:frequency: bid
Administration route: Oral
Start date: 2007-02-14
End date: 2007-02-27
Adverse event in 52 year old female receiving Zyvox (Linezolid)
Reported by a physician from United States on 2007-07-09
Patient: 52 year old female, weighing 65.8 kg (144.7 pounds)
Adverse reactions / side effects: Hypersplenism, Staphylococcal Infection, Anaemia, Thrombocytopenia, Blood Creatinine Increased, Haemorrhagic Ascites
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Intron A
Indication: Hepatitis C
Start date: 2007-01-01
PEG-Intron
Dosage: 120 mcg; qw; sc
Indication: Hepatitis C
Start date: 2007-02-01
End date: 2007-02-27
Ribavirin
Dosage: po ; 20 mg bid po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-02-14
End date: 2007-02-27
Ribavirin
Dosage: po ; 20 mg bid po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-01-01
Zyvox
Indication: Staphylococcal Infection
Start date: 2007-04-01
Adverse event in male receiving Zyvox (Linezolid)
Reported by a physician from Japan on 2007-06-29
Patient: male, weighing 53.0 kg (116.6 pounds)
Adverse reactions / side effects: White Blood Cell Count Decreased, Stomach Discomfort, Anaemia, Physical Assault, Delirium, Staphylococcal Sepsis, Verbal Abuse, Incoherent, Hallucinations, Mixed, Disease Recurrence, Platelet Count Decreased, Hypoxia, Angiopathy
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Zyvox (Linezolid)
Other drugs received by patient: Dopamine HCL; Dobutamine Hydrochloride; Hanp; Lasix; Artist; Acardi; Renivace; Aldactone; Levofloxacin
Adverse event in male receiving Zyvox (Linezolid)
Reported by a physician from Japan on 2007-06-28
Patient: male, weighing 53.0 kg (116.6 pounds)
Adverse reactions / side effects: White Blood Cell Count Decreased, Anaemia, Stomach Discomfort, Platelet Count Decreased, Angiopathy, Delirium
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Zyvox (Linezolid)
Other drugs received by patient: Dopamine HCL; Dobutamine Hydrochloride; Hanp; Lasix; Artist; Acardi; Renivace; Aldactone; Levofloxacin
Adverse event in 61 year old male receiving Zyvox (Linezolid)
Reported by a consumer/non-health professional from Spain on 2007-01-31
Patient: 61 year old male
Adverse reactions / side effects: Anaemia, Leukopenia
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Augmentin '125'
Administration route: Oral
Indication: Pulmonary Tuberculosis
Start date: 2006-01-12
Zyvox
Dosage: 600mg twice per day
Administration route: Oral
Indication: Pulmonary Tuberculosis
Start date: 2006-01-12
End date: 2006-06-08
Claritromicina
Dosage: 500mg twice per day
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2006-01-12
Ameride
Administration route: Oral
Indication: Pulmonary Tuberculosis
Start date: 2006-01-12
Other drugs received by patient: Myambutol; Moxifloxacin HCL
|
